DermaVision

UCI Senior Design 2025-2026

Making the Invisible Visible

Portable multispectral imaging technology designed to improve
bruise detection, documentation, and injury assessment
across diverse skin tones.

Making the Invisible Visible

DermaVision is developing DermaSpect, a portable multispectral imaging device that uses UV-A, visible, and near-infrared (NIR) wavelengths to capture subsurface bruise information that may not be visible under standard lighting conditions. Our goal: improve consistency, objectivity, and equity in clinical and forensic imaging.

DermaSpect isometric prototype view
DermaSpect physical prototype, isometric view

The Problem

Why This Matters

Bruise documentation plays an important role in both healthcare and forensic investigations, especially in cases involving domestic violence, sexual assault, child abuse, and physical trauma. However, current bruise assessment methods still rely heavily on visual inspection and standard photography, which are subjective and inconsistent.

According to national statistics, over 10 million domestic violence cases occur annually in the United States, and approximately 44.2% of victims are people of color. Existing bruise detection and aging methods are often less accurate on highly pigmented skin because melanin absorbs much of the visible light spectrum and can mask underlying chromophores such as hemoglobin.

As a result, bruises are often less visible or entirely missed, and documented inconsistently. This can negatively impact medical treatment, injury tracking, forensic documentation, and legal evidence collection.

10M+ Domestic violence cases per year in the U.S.
44.2% Of DV victims are people of color
~50% Accuracy of existing bruise aging methods
0 Portable NIR bruise tools validated across skin tones

Key Problem Areas

Problem Area Current Limitation
Domestic violence casesOver 10 million annually in the U.S.
Current bruise assessmentRelies heavily on subjective visual inspection
Highly pigmented skinBruises are often harder to detect visually
Existing bruise aging methodsApproximately 50% accurate
Standard photographyCaptures only visible surface information
Clinical documentationInconsistent across providers and lighting conditions
Forensic evidence collectionCan lack objective imaging support
"Bruises can be difficult for forensic nurse examiners to detect, particularly on victims with darker skin tones. An inaccurate documentation of injuries can be detrimental to the victim's legal case against their attacker as well as to the victim's medical treatment." Danielle McLeod-Henning, National Institute of Justice

Our Solution

Introducing DermaSpect

DermaSpect CAD render
DermaSpect CAD render

DermaSpect is a portable multispectral bruise quantification device designed to improve bruise visibility and documentation across diverse skin tones. Instead of relying only on visible light, the system uses multiple wavelengths of illumination, including UV-A and near-infrared (NIR), to capture subsurface information associated with bruise healing.

The system integrates specialized LEDs, a camera sensor, custom PCB electronics, and a handheld housing into a compact imaging device. By combining these components into a single platform, DermaSpect aims to provide more objective imaging compared to standard photography.

Core Features

FeaturePurpose
UV-A LEDsHighlights superficial skin features
Visible LEDsCaptures surface appearance
NIR LEDsImproves subsurface bruise visualization
Multispectral ImagingCaptures beyond visible light
Double PCB DesignCompact integration and illumination control
Phone GripPortable imaging workflow

Device Specifications

ParameterValue
Height~4.05 in
Width~4.2 in
Depth~3.6 in
Imaging ModesUV-A, Visible, NIR
Form FactorPortable handheld
ElectronicsCustom PCB system
CameraMultispectral camera

How It Works

Bruises undergo biochemical changes during healing. Chromophores such as hemoglobin and bilirubin absorb and reflect light differently over time. By imaging across multiple wavelengths, DermaSpect aims to capture spectral information associated with these changes.

  1. IlluminationUV-A, visible, or NIR LEDs illuminate the target skin region
  2. Image CaptureCamera captures spectral response from the illuminated tissue
  3. Spectral SeparationWavelength bands are isolated for analysis
  4. Feature AnalysisSpectral and spatial differences are analyzed
  5. Bruise VisualizationSubsurface bruise information becomes more visible
  6. Future GoalSupport bruise aging and injury assessment

Key Chromophores

ChromophoreRole in BruisingSpectral Relevance
HemoglobinEarly bruise colorationStrong visible/NIR absorption
BilirubinLater-stage bruise colorationIndicates bruise progression
MelaninSkin pigmentationCan obscure bruises in visible light

Design Criteria

Spring phone grip mechanism, bottom view
Spring phone grip mechanism, bottom view
ParameterDesign Goal
DurabilityProtect internal electronics and optics
Image ResolutionCapture high-quality multispectral images
FiltrationSeparate wavelength bands effectively
Spectral CoverageCapture beyond visible spectrum
PortabilityCompact handheld design
WeightLess than 2 lbs without phone
ComponentFunction
Camera CutoutHolds imaging sensor and lens
LED ArrayMultispectral illumination
Bottom PCBControls electrical subsystem
HousingProtects internal components
Phone GripStabilizes imaging device

Validation & Acceptance Criteria

ParameterAcceptance GoalValidation Method
DurabilityWithstand transport and field useVibration and drop testing
Optical ResolutionStable optical performanceModulation Transfer Function (ISO 12233)
Imaging RepeatabilityConsistent image capture across trialsRepeated acquisitions
Filtration SafetyMaintain safe exposure levelsIrradiance and luminance measurements
Risk ClassificationIEC 62471 Risk Group 0 or 1Radiometer measurements
Portability< 5 in × 4 in × 5 inCaliper measurements
Weight< 2 lbs without phoneScale measurements

Failure Mode & Effects Analysis (FMEA)

Failure ModePotential EffectMitigation Strategy
Device drop damageCamera or PCB failureImproved housing durability
Uneven LED illuminationInconsistent imagingCalibration and optical testing
Poor image acquisitionMotion blur or poor framingUser guidance and alignment controls
Phone grip spring fatiguePhone slips during imagingStronger spring materials
Housing structural failureInternal components exposedIncreased wall thickness
Excessive optical exposureSafety concernIEC 62471 testing

Current Limitations

LimitationImpact
Early-stage spectral databaseLimited training and comparison data
Lower spectral resolutionLess detail than hyperspectral systems
Calibration requirementsImaging consistency depends on setup
User alignment sensitivitySmall positioning changes affect images
Ambient lighting effectsExternal light may influence imaging
Mechanical tolerancesSome internal alignment still requires refinement

Future Development Roadmap

GoalDescription
Prototype IntegrationRefine mechanical assembly and internal alignment
Qualification TestingPerform safety and validation testing
Spectral ValidationValidate imaging consistency and illumination output
Ergonomic ImprovementsImprove housing comfort and usability
Optical Filter IntegrationComplete multispectral imaging pathway
Symposium & Final ReportPresent findings and device progress

Algorithm & Image Processing

The DermaVision algorithm pipeline is designed to analyze multispectral image data and identify spectral patterns associated with bruising. After image capture, preprocessing steps such as illumination correction and normalization are used to improve consistency between images. The system then extracts spectral and spatial features related to bruise appearance and chromophore changes during healing.

The long-term goal is to compare these spectral signatures against a bruise imaging database to support more objective bruise characterization and future time approximation. Future development may also incorporate machine learning approaches to improve classification accuracy across different skin tones and imaging conditions.

Algorithm Pipeline

StepProcess
1Multispectral image acquisition
2Image preprocessing and normalization
3Spectral and spatial feature extraction
4Pattern comparison and analysis
5Future bruise classification and aging estimation

Competitor Analysis

Current alternatives and what makes DermaSpect different.

Current bruise documentation methods each have significant limitations related to portability, spectral capability, consistency, or cost.

Current Alternatives

CompetitorTechnologyStrengthsLimitations
Nikon Z5 Standard Photography High image quality, widely available Visible light only; cannot detect subsurface bruising; poor on dark skin tones; no bruise identification and analysis
Crime-lite Auto Multispectral Illumination Alternative wavelength illumination High cost; no bruise identification and analysis; large; requires forensic training
Hyperspectral Imaging Systems Advanced spectral imaging High spectral detail and resolution Large, very expensive ($50K+), non-portable, lab-only; no bruise identification and analysis
Standard Clinical Photography Basic visible-light documentation Widely available, low cost Highly dependent on lighting and user settings; inconsistent; no bruise identification and analysis
DermaSpect Multispectral UV-A / Visible / NIR Portable, multi-wavelength, skin-tone inclusive, bruise diagnostics and analysis Moderate resolution

DermaSpect Competitive Advantages

DermaSpect AdvantageWhy It Matters
Multispectral imaging (UV-A, Visible, NIR)Captures information beyond visible light
Portable handheld designEasier clinical and forensic deployment
Lower cost potentialMore accessible than hyperspectral systems
Integrated illumination + imaging systemConsistent, self-contained imaging workflow
Validated across Fitzpatrick skin tone scaleEquitable performance across all patients
Quantitative bruise analysisSupports objective, reproducible documentation

Market Strategy

A clear path from prototype to clinical adoption.

Market Opportunity

$93.2M Forensic Imaging Market
$2.7B Dermatology Imaging Devices Market
~$6,000 Target device price per unit

Target Customer Segments

Customer GroupPotential Use Case
Police DepartmentsInjury documentation for legal evidence
Trauma CentersAcute injury monitoring and tracking
Hospitals & Emergency DepartmentsClinical documentation and SANE programs
Dermatology ClinicsSkin imaging support and diagnostics
Research LabsSpectral imaging studies and validation

Go-to-Market Approach

  • Pilot partnerships with SANE (Sexual Assault Nurse Examiner) programs and university hospital forensic nursing departments to validate clinical utility
  • Conference presence at forensic nursing (IAFN) and clinical forensic medicine conferences to build professional credibility
  • Grant and research funding through NIH and DOJ programs focused on domestic violence documentation and health equity
  • Direct sales to hospital systems and law enforcement agencies once regulatory pathway is established

Business Model Canvas

CategoryDescription
Key PartnersBeckman Laser Institute, BioENGINE, King Lab (UC Irvine)
Key ActivitiesPrototype development, testing, clinical validation
Key ResourcesResearch funding, lab space, imaging equipment
Value PropositionObjective bruise assessment across all skin tones
Customer RelationshipsSoftware support and device customization
ChannelsDirect partnerships, conference outreach, grants
Revenue StreamOne-time device purchase (~$6,000/unit)
Cost StructurePremium imaging components and fabrication

Meet the Team

UCI Biomedical Engineering Senior Design, DermaVision Hardware

Nirupama Suravarjjala

Nirupama Suravarjjala

Team Lead, Hardware & Optical Systems
Sydney Mah

Sydney Mah

Mechanical Design & Testing
Magdalena Sablan

Magdalena Sablan

Device Integration & Assembly
Yashita Nithyananthan

Yashita Nithyananthan

PCB Integration & Prototype Refinement

Faculty Mentor

Dr. Christine King, PhD Department of Biomedical Engineering, UC Irvine

Industry Mentors: DermaVision Technologies DermaVision Technologies

Jessica Lam R&D Engineer, Hardware Project Manager
Gerald Lee Operations Project Manager
Matthew Lo CEO, R&D Engineer, Algorithm Project Manager
Alejandra Reyes Clinical Project Manager

Presentation

Our full project presentation covering design, testing, and results.

Pitch

Watch our team present DermaVision.


Stop by our booth to learn more about DermaVision Technologies and see a live demonstration of DermaSpect.